Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
InPen empowers you and your patients with actionable data you've never had from your MDI patients, until now.
REQUEST INFOInPen helps MDI users take the right amount of insulin at the right time, thanks to real-time tracking and decision support.
Advanced bolus tracking and algorithms, along with intuitive reports, tell you and your patients more about their MDI therapy than ever before.
Patients can share their InPen data with you at any time. See when and how much your patients are dosing, and get full visibility into their blood glucose and carb intake. At their next appointment, you can collaborate and identify new ways to help achieve their goals.
Offer available to those with commercial insurance.
Terms and conditions apply. Learn more here.
InPen helps MDI users take the right amount of insulin at the right time, thanks to real-time tracking and decision support
✓ Tracks active insulin
✓ Reminds user to dose
✓ Calculates personalized doses
✓ Automatically logs doses
✓ Syncs with CGMs and glucose meters
Missing 2 doses per week can lead to an increase in A1C of up to 0.4%1
2 out of 3 people need help calculating their doses and 60% of doses are stacked2-4
Lack of accurate dosing data is a barrier to optimizing glycemic control5
The use of a bolus calculator is associated with a 0.7-1.0% reduction in A1C6-8
Visit the InPen virtual experience to learn more about integrating InPen into your practice.
User guides, manuals, and other helpful resources available for download.
EXPLOREOn-demand videos offer practical tips from clinical experts for using Medtronic Diabetes Therapies to help you support patients.
WATCH NOWRead about latest research in diabetes technology, practical training tips for your patients, and updates on Medtronic products.
READ ARTICLESRandlov, J., Poulsen, J.U. J Diabetes Sci Technol. 2008 Mar; 2(2): 229-235. Published online 2008 Mar. doi: [10.1177/1932296 80800200209]
Garg SK, Bookout TR, McFann KK, et al. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technology and Therapeutics. 2008; 10(5):369-375.
Zaugg, Stephanie D., et al. “Diabetes numeracy and blood glucose control: association with type of diabetes and source of care.” Clinical diabetes: a publication of the American Diabetes Association 32.4 (2014): 152-157.
Cavanaugh, Kerri, et al. “Association of numeracy and diabetes control.” Annals of Internal Medicine 148.10 (2008): 737-746.
Klonoff DC, Kerr D. Smart Pens Will Improve Insulin Therapy. J Dia Sci & Tech, 2018;12(3):551-553.
Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36(11):3613-3619.
Kaufman FR, Halvorson M, Carpenter S. Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care. 1999; 22(8):1252-1257.
Anderson DG. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII. Pediatric Diabetes. 2009; 10(5):304-309
IMPORTANT SAFETY INFORMATION FOR INPEN™ SMART INSULIN PEN:
The InPenTM requires a prescription. It is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin. The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments.
The InPenTM dose calculator, a component of the InPenTM app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user entered data.
For an insulin dose based on amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, insulin sensitivity parameters, and duration of insulin action to be programmed into the software prior to use as it is required for set up.
For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use.
For additional product and important safety considerations, see User Guide and http://bit.ly/InPenSafety.